RANI: Rani Therapeutics Inc Analyst Consensus Forecast

Rani Therapeutics (RANI) is laying the foundation for market dominance by developing robotic capsules to replace injections, although it faces certification challenges and the threat of device technical failures. The price action of the securities on GURU.Markets, where the consensus forecast stands at 7.21, illustrates the asset's dynamics. Development is localized in the US, and the humanitarian significance of the medicine protects patents from external political pressure.

RANI (Rani Therapeutics Inc) Analyst Consensus Forecast history from 07/04/2022 to 11/11/2026

Analytical breakdowns for Rani Therapeutics (RANI)

- share price and consensus valuation forecast:

Price Performance Chart ranitherapeutics.com|RANI - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Rani Therapeutics Inc|RANI - Total Company Value

- balance sheet equity data:

Equity per Share Rani Therapeutics|RANI - Book Capitalization|Market Capitalization to Book Value ranitherapeutics.com|RANI - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Equity Rani Therapeutics|RANI - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital ranitherapeutics.com|RANI - Company Aggregate Debts|Debts to Book Capitalization Rani Therapeutics Inc|RANI - Company Long-Term Debt|Company Short-Term Loans and Borrowings Rani Therapeutics|Quick Liquidity Indicator ranitherapeutics.com

- net income and valuation multiples indicators:

RANI - Net Profit|Projected Future Earnings Rani Therapeutics|RANI - Price to Earnings Ratio|Future Price to Earnings Multiple ranitherapeutics.com|RANI - Price/Earnings to Growth Ratio|Company Value to EBITDA Rani Therapeutics Inc|RANI - Operating profit before deduction of amortization|Earnings per share for the last four quarters Rani Therapeutics|RANI - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months ranitherapeutics.com|RANI - Earnings growth in current year|Expected net earnings per share growth next year Rani Therapeutics

General company analysis:RANI Rani Therapeutics Holdings

Flagship merchandise of Rani Therapeutics Holdings, Inc.

The consensus forecast determines the fair value of the business through a weighted average expert assessment, allowing investors to manage the risk of buying at the peak. The target price trajectory from analysts on GURU.Markets reflects the dynamics of market expectations, which is critical for Rani Therapeutics (RANI), whose capitalization depends not on economic cycles, but on the clinical success of innovative robotic pills.

Competitors of Rani Therapeutics